Skip to main content
. Author manuscript; available in PMC: 2019 Apr 1.
Published in final edited form as: Psychooncology. 2018 Feb 20;27(4):1221–1228. doi: 10.1002/pon.4655

Table 2.

Baseline characteristics of the participants

Characteristic Total (n=39) Control (n=13) Low-Dose (n=14) High-Dose (n=12)
Age, %
 <60 y 25 (64%) 9 (69%) 8 (57%) 8 (67%)
 ≥60 y 14 (36%) 4 (31%) 6 (43%) 4 (33%)
Sex, %
 Male 15 (38%) 4 (31%) 7 (50%) 4 (33%)
 Female 24 (62%) 9 (69%) 7 (50%) 8 (67%)
Race, %
 White 31 (80%) 8 (62%) 12 (86%) 11 (92%)
 Black 6 (15%) 3 (23%) 2 (14%) 1 (8%)
 Other 2 (5%) 2 (15%) 0 (0%) 0 (0%)
Education, %
 High School or Less 7 (18%) 1 (8%) 4 (29%) 2 (17%)
 Some College 8 (20%) 3 (23%) 2 (14%) 3 (25%)
 College Degree or More 24 (62%) 9 (69%) 8 (57%) 7 (58%)
Retired, % 11 (28%) 3 (23%) 5 (36%) 3 (25%)
Marital Status, %
 Married or Living with Partner 27 (69%) 9 (69%) 5 (64%) 9 (75%)
 Divorced, Widowed, Never Married 12 (31%) 4 (31%) 5 (36%) 3 (25%)
Smoking History, %
 Never 23 (59%) 10 (77%) 6 (43%) 7 (58%)
 Former 14 (36%) 3 (23%) 7 (50%) 4 (33%)
 Current 2 (5%) 0 (0%) 1 (7%) 1 (8%)
Consume ≥1 Alcoholic Drink/Week, % 23 (59%) 7 (54%) 9 (64%) 7 (58%)
Stage, %
 I 5 (13%) 1 (8%) 2 (14%) 2 (17%)
 II 14 (36%) 5 (38%) 5 (36%) 4 (33%)
 III 20 (51%) 7 (54%) 7 (50%) 6 (50%)
Chemotherapy, % 28 (72%) 10 (77%) 10 (71%) 8 (67%)
Time Since Treatment, %
 ≤12 months 25 (64%) 8 (62%) 10 (71%) 7 (58%)
 >12 months 14 (36%) 5 (38%) 4 (26%) 5 (42%)

Data are counts and percentages (%).